chrisvoncsefalvay/vaers-outcomes huggingface dataset:
difficulty raising her arms/difficulty turning to the right when sleeping; right shoulder is inflamed; Felt soreness of injection site; pain on right shoulder radiating down to her arm; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (difficulty raising her arms/difficulty turning to the right when sleeping), INFLAMMATION (right shoulder is inflamed), VACCINATION SITE PAIN (Felt soreness of injection site) and ARTHRALGIA (pain on right shoulder radiating down to her arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced MOBILITY DECREASED (difficulty raising her arms/difficulty turning to the right when sleeping), INFLAMMATION (right shoulder is inflamed) and ARTHRALGIA (pain on right shoulder radiating down to her arm). 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Felt soreness of injection site). At the time of the report, MOBILITY DECREASED (difficulty raising her arms/difficulty turning to the right when sleeping), INFLAMMATION (right shoulder is inflamed), VACCINATION SITE PAIN (Felt soreness of injection site) and ARTHRALGIA (pain on right shoulder radiating down to her arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Client was vaccinated in the triceps area of the arm instead of the deltoid. The vaccinator stated that the client was very frail and he did not feel there was enough muscle mass in the deltoid to administer the vaccine there. He opted to give the vaccine in the triceps instead.   Vaccinator has been counseled on this and explained that a better muscle to use would have been the anterolateral thigh. Per information from CDC, this dose does not need to be repeated. District Nurse Manager followed up on client today (3/26/2021), and client only complains of soreness in arm at site of injection.
Pt was given flu vaccine at approximately 10 AM. She noted an intense rash around 4 PM. Advised pt to take Benadryl and go to emergency room if condition changed.
Shortness of breath and facial swelling occurred shortly after Zostavax administration. Patient returned to clinic and received 2 doses of epinephrine 0.3 mg IM. Symptoms were improving, but patient was sent to an outside hospital ED via EMS. Patient was treated with prednisone at the outside ED and symptoms resolved.
Information has been received from a office manager referring to an unspecified number of patients of unknown ages and unknown genders. Information of concomitant medication, concurrent condition, pertinent medical history and drug reactions/allergies was not provided. On unspecified dates, the patients was administered improperly stored GARDASIL 9 (lot# N021571 with expiration date 29-APR-2020, lot #M037770 with expiration date 01-JUN-2019; strength, dose detail and route were not reported) (product storage error) for prophylaxis. The GARDASIL 9 were exposed to temperature excursion of 47 fahrenheit degree to 77 fahrenheit degree (also reported as 55 fahrenheit degree) for 7 hours and 10 minutes and previous temperature excursion of 47 fahrenheit degree to 77 fahrenheit degree for 14 hours and 20 minutes. No adverse effects was reported. Data logger was involved. This case was determined to be non-valid as no patient identifier.
DIFFICULTY BREATHING; FELT LIKE KNIVES IN LUNGS.; This spontaneous report received from a patient concerned a 67 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included lung problems.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: unknown) dose was not reported, administered on 2021 for covid-19 vaccination. Concomitant medications included risankizumab for chronic plaque psoriasis.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers On 2021, the subject experienced difficulty breathing. On 2021, the subject experienced felt like knives in lungs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the difficulty breathing and felt like knives in lungs. was not reported. This report was non-serious.
I had bodyaches, fever of 101.4, nausea, chills, headache that started at 2230 on 12/24/2020. Tylenol was taken and fever continued to increase. Hip joint is stiff and walking is difficult.
Pt. tested positive for covid-10 on 09/14/2021. He was sent home to quarantine.  On 9/22/21, he was seen in the  ER for SOB. He was given dexamethasone and a duoneb and sent home in stable condition.  On 9/29/2021, pt. returned to the ER with SOB, fever and fatigue. He was admitted to the hospital for hypoxemia, he stayed two days and was discharged on 10/1/2021 in stable condition.
Tested positive for pertussis on sample collected 6/24/10. Exposed to confirmed case(s).
Red, swollen arm and low grade fever (99.7) with pain on 9/20/17 at noon. By 3:30 pm, she had a fever of 101.7, was lethargic and couldn't lift arm. Was given 1 1/2 tsp children's ibuprofen and continued to have 101.7 fever; she was still lethargic but also became somewhat giddy and "out of it." Before bedtime she developed hives around the injection site and was given a dose of Benadryl. Overnight, her fever spiked and went over 102. She was dizzy and needed help getting to the bathroom, complained of pain in her red, incredibly swollen arm. As of 9/21, she still has arm pain and the redness has extended to her elbow. She was seen by a doctor in the Urgent Care, who recorded her symptoms. She also has a scratch near the injection site that we are monitoring for infection.
Patient was given a combination DTaP/Polio (KINRIX) instead of separate vaccines.
Hives, Trouble breathing Took 3 Benadryl 25mg Lasted about two hours until I felt better.
Covid booster given to early second dose give 5/21/21 and booster dose given 10/25/21
The patient's arm became inflamed at the injection site. The patient also stated that she was feverish.
Has problems when looks to the left and looks to the right, looks up or looks down; Suffering from migraine headaches that are severe ever since receiving the second dose Pfizer Covid 19 Vaccine; This is a spontaneous report received from a contactable consumer.  A 19-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 26Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 26Apr2021, the patient experienced suffering from migraine headaches that are severe ever since receiving the second dose pfizer covid 19 vaccine and the headaches were very debilitating. On an unspecified date, the patient has problems when looks to the left and looks to the right, looks up or looks down, it began a few weeks after the patient received the second dose Pfizer Covid 19 Vaccine and then it has worsened. The reporter stated that to know if the patient will have long term issues because of this and need the patient to see an optic nerve specialist. The outcome of the events was not resolved.   Information about batch/Lot number has been requested.
Panic Attack; Short of Breath; Headache; Sore Injection Site; Hard to the touch Injected Muscle; Temperature 99.3F; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site) and MYALGIA (Hard to the touch Injected Muscle) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jun-2021, the patient experienced PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Headache, at a dose of 1 dosage form. At the time of the report, PANIC ATTACK (Panic Attack), DYSPNOEA (Short of Breath), HEADACHE (Headache), VACCINATION SITE PAIN (Sore Injection Site), MYALGIA (Hard to the touch Injected Muscle), PYREXIA (Temperature 99.3F) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jun-2021, Blood pressure measurement: 180 mmHg (High) High systolic pressure.. On 18-Jun-2021, Body temperature: 99.3 farenheit (High) Slightly increased.         The action taken with mRNA-1273 in response to the event is not applicable.  It is reported that the patient had went to emergency room and the health professionals have planned to test the patient for COVID-19.   This case was linked to MOD-2021-186788 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of adverse event in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX (intramuscular). On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse event (serious criteria hospitalization). On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The reporter heard that, an unknown patient had to be hospitalized due to SHINGRIX dose. No other details were available.
I started feeling extremely weak and tired, which never happens to me. Then I noticed that it was hard to breathe and felt as if my asthma was kicking in. I also noticed that my heart rate was racing and felt as if my whole body was shaking. Per my heart rate monitor, my HR was at 97 sitting, when normally this is around 68. Luckily I went home and was able to use my inhaler to help my breathing. The next day, I feel better, but definitely not 100%.
Patient was given 0.3mL dose of Pfizer vaccine (adult dose) instead of pediatric dose of 0.1mL
Patient got the first dose from an expired vial; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got the first dose from an expired vial) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got the first dose from an expired vial). On 04-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Patient got the first dose from an expired vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Child received Tdap-Boostrix Lot # C2770AA instead of DTaP Infanrix Lot # AC14B060AB. Mother was notified on 09/03/2008.
28 year old female is received in the area of vaccination COVID-19 Hospital to administer the second dose vaccine PFIZER. After collecting all data patient informs having an allergic reaction to the first dose vaccine against COVID-19 PFIZER. She refers "After having administered the first dose of PFIZER vaccine, I started with heavy bleeding with clots. The same night I was administered the vaccine until the next day, it was not time for my period, and usually I bleed very little" It is recommended to visit her primary doctor before administering second dose. She expresses and authorizes the administration of the second dose and signs the consent. She is advised to visit the nearest emergency room in the event of bleeding. The second dose is administered with aseptic measures, the patient had no adverse reaction during the 15 minute wait.
I started experiencing immense pain throughout my entire body. I had difficulty walking because I  was in so much pain. I could not sleep during most of the night because I was in so much pain.  This morning by about 10:00 am the pain had subsided quite a bit and I was able to get up and eat a slice of toast but immediately fell back to sleep. About 2:00 pm I was able to take a shower and my right arm is still a little sore but I feel like I am getting back to normal. My brain seemed foggy to me last night and this morning but I am back to normal now.
Patient is a 82 y.o. male admitted to the hospital on 9/3/2023 for weakness, expressive aphasia.  Patient found to have abscess due to COVID-19.  Patient was treated supportively.  His acute hypoxic respiratory failure resolved with dexamethasone and he was on room air at the time of discharge.  Imaging completed did not show any evidence of CVA.  Patient was discharged on hospital day 4 in stable condition with PCP follow-up.  His dexamethasone was discontinued prior to discharge.  It was felt the risk of delirium, adverse effects from interactions with dexamethasone/warfarin outweighed the benefit. Sepsis due to COVID-19 Infection- POA resolved - Presented with: Encephalopathy, fevers, cough - Symptom onset: Unclear. - Positive COVID-19: 9/4 at RMH - Vaccination status: Vaccinated with Pfizer with last dose 9/2022 - CT Chest on admission showed Pulm nodules previously known, no sign of PNA - Oxygen status: Room air - Decadron: Yes, discontinued prior to discharge - Remdesivir: No.  -UA-no infection. CT C/A/P-no acute abnormality.    Acute Respiratory Resp Failure with Hypoxia -Appears to be more in the setting of multifactorial deconditioning, recent back surgery, and weakness from COVID -Dexamethasone discontinued -Weaned off of O2   Acute toxic encephalopathy-resolved Aphasia-improved Gait imbalance-resolved Felt to be due to sepsis, COVID-19 infection. -Neurology followed: CT head normal, CT head and neck normal, MR brain normal. -Expressive aphasia improved substantially on 9/6. -PT/OT followed.  Health home care discharge.   Acute on chronic lower back pain-resolved Lumbar radiculopathy -Recent ESI at Ortho one on 8/29 which did not work as per patient's wife. -CT L-spine-degenerative changes of the lumbar spine most notably at L3-L4 where right facet arthrosis contributes to severe right subarticular recess stenosis and severe right foraminal stenosis. -Evaluated by neurosurgery. -MRI L-spine with post-surgical changes and a postoperative seroma. Anterolisthesis of L5-S1. No infected collections noted.   Transaminitis -AST 63, ALT 45, likely due to COVID -Resolved Mild neurocognitive disorder -Continue Namenda.   Paroxysmal atrial fibrillation Supratherapeutic INR -Controlled on metoprolol. -On Coumadin with INR 2.3, INR 3.6 9/4 -Continue Warfarin, dose per pharmacy   History of DVT and PE -In 2006. -On Coumadin.   History of CVA -With mild residual aphasia and left-sided weakness. -Resume Plavix   Hypertension -BP mildly elevated. -Resume BP meds
Patient administered Pfizer dose with expiration of 11/30/2021 and BUD of 11/28/2021.
sore arm; Neck Pain; Shoulder Pain (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NECK PAIN (Neck Pain) and INJECTION SITE PAIN (Shoulder Pain (Injection Site)) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NECK PAIN (Neck Pain) and INJECTION SITE PAIN (Shoulder Pain (Injection Site)). At the time of the report, PAIN IN EXTREMITY (sore arm), NECK PAIN (Neck Pain) and INJECTION SITE PAIN (Shoulder Pain (Injection Site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
their first shot more than six months ago; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first shot on an unknown date more than six months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the second dose, which led to incomplete course of vaccination. The reporter wanted to know what should he/she advise his/her patient if they received their first shot more than six months ago.
Tingling in finger tips and face started several days after receiving the vaccine. By May 25th, scalp was itching and red dots that seemed like mosquito bites started appearing on right side of face. Right side of face started swelling up and becoming red by late May and by June 1st I was diagnosed with shingles. In 3 days symptoms lessened. Within 2 weeks swelling had disappeared. At present there is still periodic itching on face and scalp. Scaring above right brow.  Doctor prescribed Acyclovir 800 mg tablets, 5 x a dime for 7 days and Acyclovir Cream.  Two days after vaccination, lymph nodes under left shoulder visibly swollen and sore. Swelling lasted several days.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 01-MAR-2016, the patient was vaccinated with improperly stored VAQTA (lot # L015460, expiration date 20-JUL-2017, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Day after vaccine: muscle aches 2 days after vaccine: fever of 102.5, fatigue, muscle aches, chills, redness and swelling at injection site
Information has been received from a registered nurse concerning an 8 year old white male hcild who on 29SEP1995 was vaccinated SC in the thigh with a first dose of varicella virus vaccine live. Additonal therapy given on 29SEP1995 included a first dose of measles virus vaccine live+mumps virus vaccine live+rubella virus vaccine live administered SC in the thigh and a fourth dose of diptheria toxoid+ HIB conj vaccine+ pertussis whole cell vaccine+tetanus toxoid administered IM in the thigh. The registered nurse reported that "over the weekend", he had a fever also reported by registered nurse as 11MAY2003), and the rash began on 12MAY2003. It was also noted that on 12MAY2003, the child had an itch on his back, "asked his mother to scratch it", and she noticed a chickenpox rash. The nurse reported that he had about 25 lesions on his back and front and  a few on his legs". It was also noted the patient had a headache. The reporter indicated the patient visited the physician for diagnosis. There was no product quality complaint reported. Additional information has been requested.
SEIZURES; PARALYSIS ON ONE SIDE OF BODY; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age (teenager), race and ethnicity. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) 1 total dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced seizures, and paralysis on one side of body, and on an unspecified date, she was hospitalized. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the seizures and paralysis on one side of body was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210530732-covid-19 vaccine ad26.cov2.s-seizures and paralysis on one side of body. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Extremely large amounts of bleeding into bladder during the release of kidney stone. Taken to OR for insertion of urethra tube. Follow-up Fragmentation procedure on 6/7/2021 caused large amounts of blood loss and blood clots the size of quarters into the urine. Blood loss and excessive clotting lasted for 5+ days.
reports getting 1st dose of Moderna vaccine 3/12/21, then 3/14 started with ringing in the ear and muffled sounds. Now is having a hard time hearing at all, but ringing has resolved. Also reports some nasal congestion which has also resolved
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with improperly stored dose of VARIVAX (dose, frequency and route of administration were not provided) lot# N017700 and expiration date: 09-JUN-2019. The VARIVAX was reconstituted with properly stored dose of sterile diluent (manufacturer unknown). No adverse effect was reported. The vaccine was stored in between 15 degrees Fahrenheit (F) to 46 F for 1 hour and 9 minutes. Previous temperatures excursions were in between 6 F 14 F for 76 minutes and in between 15 F to 46 F for 1 hour and 23 minutes. The digital data logger was involved in recording the temperature excursion. No causality assessment was provided by the reporter. Sender's Comments: US-009507513-1711USA002012.
pt family noted pus from site 18OCT98 swelling & warmth of lt deltoid muscle;spoke w/MD on call & was told to be seen 19OCT98;examined on 19AUG98 found to have cellulitis;
No symptoms for first 24 hours. After 24 hours developed bright redness and swelling forming a welt around injection site that is warm to the touch. The area feels tender and sensitive to pressure and is also slightly itchy. Small red dots are present around the injection site and dissipate further from center of the welt. Within 27 hours of injection whole body muscle soreness/ tightness, fever, chills, shakes/ trembling, loss of appetite, lethargy, insomnia, and general flushed appearance. Symptoms lasted over 12 hours. Feverish symptoms disappeared but muscle aches, lethargy, and welt at injection site are still present.
10 mm x 10 mm Erythema surrounding injection site of DTap c/o area itching, OTC Benadryl given.